Human pathology

Home page > Technical section > Providers in pathology > Ventana

Ventana

Website

News

- [December 6, 2007] Roche has renewed several times a bid to take over Ventana for $75 a share, or around $3 billion, which was a 55 percent premium over Ventana’s value over the three months before the June 2007 offer.